Literature DB >> 18656727

The effect of comorbidity on quality of life during radiotherapy in head and neck cancer.

Nashreen Banon Oozeer1, Jen Benbow, Carole Downs, Charles Kelly, Andrew Welch, Vinidh Paleri.   

Abstract

OBJECTIVE: To identify the impact of comorbidity on quality of life during radiotherapy in head and neck cancer patients. STUDY
DESIGN: Prospective assessment of quality of life and retrospective assessment of comorbidity. SUBJECTS AND METHODS: Patients' quality of life was assessed at the start and twice during radiation treatment with the University of Washington Quality of Life questionnaire. Comorbidity was assessed from the case notes of 91 patients with the Adult Comorbidity Evaluation-27 index.
RESULTS: A mean comorbidity burden of 1.07 was found. Comorbid illnesses afflicted a little more than 60 percent of our cohort. Patients with moderate to severe comorbidity had statistically significantly worse quality of life at the start (P = 0.044) and midpoint of treatment (P = 0.005), but not at the end of treatment (P = 0.114). The magnitude of change of these scores after treatment was not influenced by comorbidity.
CONCLUSION: On the basis of severity of decompensation, radiotherapy does not produce a differential impact on the quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18656727     DOI: 10.1016/j.otohns.2008.05.027

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  1 in total

1.  Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients.

Authors:  Arild André Østhus; Anne K H Aarstad; Jan Olofsson; Hans J Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-09       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.